The global liquid biopsy market was valued at USD 10.42 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 11.60% from 2024 to 2030. The market's growth is primarily driven by several key factors, including the rising prevalence of cancer worldwide, continuous technological advancements in cancer diagnostics, and an increasing preference for minimally invasive...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian